RxDoctor Payments Data

Lynda Mc Hutchison, MD

Obstetrics & Gynecology · Durham, NCNPI 1417136508

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Cashflow Solutions, LLC at 45.7% of the total.

$648in general payments, 2019–2025

Across 56 payments — averaging $11.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cashflow Solutions, LLC$296
  • Bard Peripheral Vascular, Inc.$185
  • Genentech USA, Inc.$123
  • Venclose Inc.$25
  • Medtronic$19
$58,743in research payments, 2019–2025

Across 14 payments — averaging $4195.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cashflow Solutions, LLC$50K
  • Medline Industries LP$9K

What the payments were for

  • Food & beverage$648100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cashflow Solutions, LLC51$296
Bard Peripheral Vascular, Inc.2$185
Genentech USA, Inc.1$123
Venclose Inc.1$25
Medtronic1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$648 in reported general payments places this provider in the 55th percentile of 1,344 obstetrics & gynecology providers in North Carolina.

See all obstetrics & gynecology providers in North Carolina

Medicare billing

Part B allowed, 2024
$521,849
Medicare patients
206
Services billed
923

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$16,187

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →